3.86

8.43% 0.30

After Hours: 3.85 -0.010 -0.26%

Hyperion Defi Inc (HYPD)

Overview News Price History Discussions Forecast

Hyperion Defi Inc stock is traded at $3.86, with a volume of 268.75K. It is up +8.43% in the last 24 hours and up +8.12% over the past month. Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its on-chain utility. It is working to provide its shareholders with simplified exposure to the Hyperliquid ecosystem, which is believed to be among the highest-revenue-generating blockchains in the world, according to information from various blockchain data tracking sources, including Artemis Analytics and DefiLlama.

Previous Close:

$3.56

Open:

$3.63

24h Volume:

268.75K

Relative Volume:

0.71

Market Cap:

$43.97M

Revenue:

$813.50K

Net Income/Loss:

$-45.31M

P/E Ratio:

-0.4433

EPS:

-8.707

Net Cash Flow:

$-86.72M

1W Performance:

+20.25%

1M Performance:

+8.12%

6M Performance:

-49.74%

1Y Performance:

+0.00%

1-Day Range:

$3.57

$3.87

1-Week Range:

$3.13

$3.87

52-Week Range:

$2.761

$16.12

Hyperion Defi Inc Stock (HYPD) Company Profile

Name

Hyperion Defi Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

833-393-6684

Address

295 MADISON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2026-03-26

Latest SEC Filings

HYPD's Discussions on Twitter

Compare HYPD vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYPD Hyperion Defi Inc	3.86	40.55M	813.50K	-45.31M	-86.72M	-8.707
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-24-25	Initiated	Chardan Capital Markets	Buy
Dec-16-25	Initiated	Cantor Fitzgerald	Overweight
Nov-18-24	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-01-21	Initiated	Northland Capital	Outperform
Feb-03-20	Downgrade	Oppenheimer	Outperform → Perform

Hyperion Defi Inc Stock (HYPD) Latest News

Apr 14, 2026

Hyperion DeFi anticipates $4M–$6M adjusted gross profit in 2026 amid expanding DeFi monetization and ecosystem partnerships - MSN

Apr 14, 2026

Apr 09, 2026

Hyperion DeFi to join Hyperliquid community in Seoul for ecosystem collaboration - Traders Union

Apr 09, 2026

Apr 07, 2026

Hyperion DeFi (NASDAQ:HYPD) versus Neuren Pharmaceuticals (OTCMKTS:NURPF) Critical Survey - Defense World

Apr 07, 2026

Apr 01, 2026

HYPERION DEFI (HYPD) CFO has 20,831 shares withheld for tax obligations - Stock Titan

Apr 01, 2026

Avanza Pension reports 9.88% stake in Hyperion DeFi (NASDAQ: HYPD) - stocktitan.net

Apr 01, 2026

Mar 30, 2026

Hyperion DeFi 2025 10-K: $0.81M Revenue, $(45.3)M Net Loss - TradingView

Mar 30, 2026

Mar 28, 2026

Hyperion DeFi partners with Silhouette trading platform - MSN

Mar 28, 2026

Analysts Offer Insights on Healthcare Companies: Hyperion DeFi (HYPD), Kyverna Therapeutics, Inc. (KYTX) and Medios AG (OtherMEDOF) - The Globe and Mail

Mar 28, 2026

Hyperion DeFi, Inc. Q4 earnings preview - MSN

Mar 28, 2026

Mar 27, 2026

Hyperion DeFi Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2026

Hyperion DeFi (NASDAQ: HYPD) outlines HYPE token treasury risks and Optejet plans - Stock Titan

Mar 27, 2026

Hyperion DeFi Reports Strong Growth Amid Crypto Volatility - The Globe and Mail

Mar 27, 2026

Chardan Raises Price Target on Hyperion DeFi to $8.25 From $7.75, Keeps Buy Rating - marketscreener.com

Mar 27, 2026

Hyperion DeFi, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HYPD) 2026-03-27 - Seeking Alpha

Mar 27, 2026

Hyperion DeFi Reports 64% Q4 Revenue Growth, HYPE Token Surges 60% YTD - KuCoin

Mar 27, 2026

Hyperion DeFi Reports 64% Revenue Growth and 87% Adjusted Gross Profit Surge in Q4 2025, Projects 4x Profit Increase for 2026 - Minichart

Mar 27, 2026

Chardan Capital Maintains Hyperion DeFi(HYPD.US) With Buy Rating, Raises Target Price to $8.25 - Moomoo

Mar 27, 2026

Hyperion DeFi Q4 2025 slides: 87% profit growth amid token volatility By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 26, 2026

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit - markets.businessinsider.com

Mar 26, 2026